Gideon Schreiber, PhD

Chronic lymphocytic leukemia (CLL) is a blood cancer characterized by overproduction of lymphocytes, a white blood cell. Kinase-inhibitor drugs can extend a patient’s life, but do not cure CLL because some cancer cells stay hidden. Using a mouse model, the Schreiber lab will try to determine whether combining kinase inhibitors with treatments that block the interferon response can successfully treat CLL. The results obtained should, ultimately, provide the basis for designing clinical trials.

View Grant Recipient Profile